Post-transcriptional regulation of CD83 expression by AUF1 proteins

Nucleic Acids Research

Volumn 41, Issue 1, 2013, Pages 206-219

  Ehlers, Christina ^a   Schirmer, Susann ^a   Kehlenbach, Ralph H ^b   Hauber, Joachim ^a   Chemnitz, Jan ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HUR PROTEIN; MESSENGER RNA;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE SILENCING; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY SEQUENCE; RNA TRANSLATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; GENE EXPRESSION REGULATION; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HUMANS; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA INTERFERENCE;

MAMMALIA;

EID: 84871819550     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks1069     Document Type: Article

References (81)

1. Zhou, L.J., Schwarting, R., Smith, H.M. and Tedder, T.F. (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol., 149, 735-742.
2. Zhou, L.J. and Tedder, T.F. (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol., 154, 3821-3835.
3. Lechmann, M., Zinser, E., Golka, A. and Steinkasserer, A. (2002) Role of CD83 in the immunomodulation of dendritic cells. Int. Arch. Allergy Immunol., 129, 113-118.
4. Prechtel, A.T. and Steinkasserer, A. (2007) CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res., 299, 59-69.
5. Kretschmer, B., Luthje, K., Guse, A.H., Ehrlich, S., Koch-Nolte, F., Haag, F., Fleischer, B. and Breloer, M. (2007) CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. PLoS One, 2, e755.
6. Prazma, C.M., Yazawa, N., Fujimoto, Y., Fujimoto, M. and Tedder, T.F. (2007) CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo. J. Immunol., 179, 4550-4562.
7. Chemnitz, J., Turza, N., Hauber, I., Steinkasserer, A. and Hauber, J. (2010) The karyopherin CRM1 is required for dendritic cell maturation. Immunobiology, 215, 370-379.
8. Cao, W., Lee, S.H. and Lu, J. (2005) CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem. J., 385, 85-93.
9. Nicod, L.P., Joudrier, S., Isler, P., Spiliopoulos, A. and Pache, J.C. (2005) Upregulation of CD40, CD80, CD83 or CD86 on alveolar macrophages after lung transplantation. J. Heart Lung Transplant., 24, 1067-1075.
10. Yamashiro, S., Wang, J.M., Yang, D., Gong, W.H., Kamohara, H. and Yoshimura, T. (2000) Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood, 96, 3958-3963.
11. Scholler, N., Hayden-Ledbetter, M., Dahlin, A., Hellstrom, I., Hellstrom, K.E. and Ledbetter, J.A. (2002) Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol., 168, 2599-2602.
12. Senechal, B., Boruchov, A.M., Reagan, J.L., Hart, D.N. and Young, J.W. (2004) Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood, 103, 4207-4215.
13. Fujimoto, Y. and Tedder, T.F. (2006) CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J. Med. Dent. Sci., 53, 85-91.
14. Fujimoto, Y., Tu, L., Miller, A.S., Bock, C., Fujimoto, M., Doyle, C., Steeber, D.A. and Tedder, T.F. (2002) CD83 expression influences CD4+ T cell development in the thymus. Cell, 108, 755-767.
15. Breloer, M. and Fleischer, B. (2008) CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol., 29, 186-194.
16. Dudziak, D., Nimmerjahn, F., Bornkamm, G.W. and Laux, G. (2005) Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J. Immunol., 174, 6672-6676.
17. Hock, B.D., Kato, M., McKenzie, J.L. and Hart, D.N. (2001) A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int. Immunol., 13, 959-967.
18. Hock, B.D., Haring, L.F., Steinkasserer, A., Taylor, K.G., Patton, W.N. and McKenzie, J.L. (2004) The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. Leuk. Res., 28, 237-241.
19. Lechmann, M., Krooshoop, D.J., Dudziak, D., Kremmer, E., Kuhnt, C., Figdor, C.G., Schuler, G. and Steinkasserer, A. (2001) The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med., 194, 1813-1821.
20. Scholler, N., Hayden-Ledbetter, M., Hellstrom, K.E., Hellstrom, I. and Ledbetter, J.A. (2001) CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected]. J. Immunol., 166, 3865-3872.
21. Zinser, E., Lechmann, M., Golka, A., Lutz, M.B. and Steinkasserer, A. (2004) Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med., 200, 345-351.
22. Ge, W., Arp, J., Lian, D., Liu, W., Baroja, M.L., Jiang, J., Ramcharran, S., Eldeen, F.Z., Zinser, E., Steinkasserer, A. et al. (2010) Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection. Transplantation, 90, 1145-1156.
23. Lan, Z., Lian, D., Liu, W., Arp, J., Charlton, B., Ge, W., Brand, S., Healey, D., DeBenedette, M., Nicolette, C. et al. (2010) Prevention of chronic renal allograft rejection by soluble CD83. Transplantation, 90, 1278-1285.
24. Banchereau, J. and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature, 392, 245-252.
25. Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271-296.
26. Lechmann, M., Berchtold, S., Hauber, J. and Steinkasserer, A. (2002) CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol., 23, 273-275.
27. Berchtold, S., Muhl-Zurbes, P., Maczek, E., Golka, A., Schuler, G. and Steinkasserer, A. (2002) Cloning and characterization of the promoter region of the human CD83 gene. Immunobiology, 205, 231-246.
28. Kruse, M., Rosorius, O., Kratzer, F., Bevec, D., Kuhnt, C., Steinkasserer, A., Schuler, G. and Hauber, J. (2000) Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. Med., 191, 1581-1590.
29. Kohler, A. and Hurt, E. (2007) Exporting RNA from the nucleus to the cytoplasm. Nat. Rev. Mol. Cell Biol., 8, 761-773.
30. Carmody, S.R. and Wente, S.R. (2009) mRNA nuclear export at a glance. J. Cell Sci., 122, 1933-1937.
31. Schutz, S., Chemnitz, J., Spillner, C., Frohme, M., Hauber, J. and Kehlenbach, R.H. (2006) Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway. J. Mol. Biol., 358, 997-1009.
32. Prechtel, A.T., Chemnitz, J., Schirmer, S., Ehlers, C., Langbein-Detsch, I., Stulke, J., Dabauvalle, M.C., Kehlenbach, R.H. and Hauber, J. (2006) Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. J. Biol. Chem., 281, 10912-10925.
33. Pieper, D., Schirmer, S., Prechtel, A.T., Kehlenbach, R.H., Hauber, J. and Chemnitz, J. (2011) Functional characterization of the HuR:CD83 mRNA interaction. PLoS One, 6, e23290.
34. Fornerod, M., Ohno, M., Yoshida, M. and Mattaj, I.W. (1997) CRM1 is an export receptor for leucine-rich nuclear export signals. Cell, 90, 1051-1060.
35. Hutten, S. and Kehlenbach, R.H. (2007) CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol., 17, 193-201.
36. Ma, W.J., Cheng, S., Campbell, C., Wright, A. and Furneaux, H. (1996) Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem., 271, 8144-8151.
37. King, P.H., Levine, T.D., Fremeau, R.T. Jr and Keene, J.D. (1994) Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor. J. Neurosci., 14, 1943-1952.
38. Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J.B. and Furneaux, H.M. (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell, 67, 325-333.
39. Good, P.J. (1995) A conserved family of Elav-like genes in vertebrates. Proc. Natl Acad. Sci. USA, 92, 4557-4561.
40. Keene, J.D. (1999) Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl Acad. Sci. USA, 96, 5-7.
41. Brennan, C.M. and Steitz, J.A. (2001) HuR and mRNA stability. Cell Mol. Life Sci., 58, 266-277.
42. Hinman, M.N. and Lou, H. (2008) Diverse molecular functions of Hu proteins. Cell Mol. Life Sci., 65, 3168-3181.
43. Bakheet, T., Williams, B.R. and Khabar, K.S. (2006) ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res., 34, D111-D114.
44. Fries, B., Heukeshoven, J., Hauber, I., Gruttner, C., Stocking, C., Kehlenbach, R.H., Hauber, J. and Chemnitz, J. (2007) Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression. J. Biol. Chem., 282, 4504-4515.
45. Chemnitz, J., Pieper, D., Gruttner, C. and Hauber, J. (2009) Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression. Eur. J. Immunol., 39, 267-279.
46. Barreau, C., Paillard, L. and Osborne, H.B. (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res., 33, 7138-7150.
47. Brewer, G. (1991) An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol., 11, 2460-2466.
48. Zhang, W., Wagner, B.J., Ehrenman, K., Schaefer, A.W., DeMaria, C.T., Crater, D., DeHaven, K., Long, L. and Brewer, G. (1993) Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol., 13, 7652-7665.
49. Gratacos, F.M. and Brewer, G. (2010) The role of AUF1 in regulated mRNA decay. Wiley. Interdiscip. Rev. RNA, 1, 457-473.
50. Wagner, B.J., DeMaria, C.T., Sun, Y., Wilson, G.M. and Brewer, G. (1998) Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics, 48, 195-202.
51. Wilson, G.M. and Brewer, G. (1999) The search for trans-acting factors controlling messenger RNA decay. Prog. Nucleic Acid Res. Mol. Biol., 62, 257-291.
52. Buzby, J.S., Brewer, G. and Nugent, D.J. (1999) Developmental regulation of RNA transcript destabilization by A+U-rich elements is AUF1-dependent. J. Biol. Chem., 274, 33973-33978.
53. He, C. and Schneider, R. (2006) 14-3-3sigma is a p37 AUF1-binding protein that facilitates AUF1 transport and AU-rich mRNA decay. EMBO J., 25, 3823-3831.
54. Loflin, P., Chen, C.Y. and Shyu, A.B. (1999) Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev., 13, 1884-1897.
55. Sarkar, B., Xi, Q., He, C. and Schneider, R.J. (2003) Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell Biol., 23, 6685-6693.
56. Lu, J.Y., Sadri, N. and Schneider, R.J. (2006) Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev., 20, 3174-3184.
57. Cullen, B.R. (1986) Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell, 46, 973-982.
58. Rosorius, O., Heger, P., Stelz, G., Hirschmann, N., Hauber, J. and Stauber, R.H. (1999) Direct observation of nucleocytoplasmic transport by microinjection of GFP-tagged proteins in living cells. Biotechniques, 27, 350-355.
59. Daly, T.J., Doten, R.C., Rennert, P., Auer, M., Jaksche, H., Donner, A., Fisk, G. and Rusche, J.R. (1993) Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry, 32, 10497-10505.
60. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
61. Heger, P., Rosorius, O., Hauber, J. and Stauber, R.H. (1999) Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans-dominant HTLV-1 rex mutants. Oncogene, 18, 4080-4090.
62. McKinsey, T.A., Chu, Z., Tedder, T.F. and Ballard, D.W. (2000) Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes. Mol. Immunol., 37, 783-788.
63. Ziegler-Heitbrock, H.W., Thiel, E., Futterer, A., Herzog, V., Wirtz, A. and Riethmuller, G. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer, 41, 456-461.
64. Cullen, B.R. (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol., 152, 684-704.
65. Liao, B., Hu, Y. and Brewer, G. (2007) Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation. Nat. Struct. Mol. Biol., 14, 511-518.
66. Wilson, G.M., Sun, Y., Lu, H. and Brewer, G. (1999) Assembly of AUF1 oligomers on U-rich RNA targets by sequential dimer association. J. Biol. Chem., 274, 33374-33381.
67. Wilson, G.M., Lu, J., Sutphen, K., Sun, Y., Huynh, Y. and Brewer, G. (2003) Regulation of A+U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1. J. Biol. Chem., 278, 33029-33038.
68. Malim, M.H., Hauber, J., Le, S.Y., Maizel, J.V. and Cullen, B.R. (1989) The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature, 338, 254-257.
69. Xu, N., Loflin, P., Chen, C.Y. and Shyu, A.B. (1998) A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res., 26, 558-565.
70. Loflin, P.T., Chen, C.Y., Xu, N. and Shyu, A.B. (1999) Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells. Methods, 17, 11-20.
71. Lu, J.Y., Bergman, N., Sadri, N. and Schneider, R.J. (2006) Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay. RNA, 12, 883-893.
72. Stoecklin, G., Lu, M., Rattenbacher, B. and Moroni, C. (2003) A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway. Mol. Cell Biol., 23, 3506-3515.
73. Lund, N., Milev, M.P., Wong, R., Sanmuganantham, T., Woolaway, K., Chabot, B., Abou, E.S., Mouland, A.J. and Cochrane, A. (2012) Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. Nucleic Acids Res., 40, 3663-3675.
74. Chen, T.M., Hsu, C.H., Tsai, S.J. and Sun, H.S. (2010) AUF1 p42 isoform selectively controls both steady-state and PGE2-induced FGF9 mRNA decay. Nucleic Acids Res., 38, 8061-8071.
75. Sarkar, S., Sinsimer, K.S., Foster, R.L., Brewer, G. and Pestka, S. (2008) AUF1 isoform-specific regulation of anti-inflammatory IL10 expression in monocytes. J. Interferon Cytokine Res., 28, 679-691.
76. Pautz, A., Linker, K., Altenhofer, S., Heil, S., Schmidt, N., Art, J., Knauer, S., Stauber, R., Sadri, N., Pont, A. et al. (2009) Similar regulation of human inducible nitric-oxide synthase expression by different isoforms of the RNA-binding protein AUF1. J. Biol. Chem., 284, 2755-2766.
77. Sarkar, B., Lu, J.Y. and Schneider, R.J. (2003) Nuclear import and export functions in the different isoforms of the AUF1/heterogeneous nuclear ribonucleoprotein protein family. J. Biol. Chem., 278, 20700-20707.
78. Chen, C.Y., Xu, N., Zhu, W. and Shyu, A.B. (2004) Functional dissection of hnRNP D suggests that nuclear import is required before hnRNP D can modulate mRNA turnover in the cytoplasm. RNA, 10, 669-680.
79. Zhai, B., Yang, H., Mancini, A., He, Q., Antoniou, J. and Di Battista, J.A. (2010) Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway. J. Biol. Chem., 285, 23568-23580.
80. Lal, A., Abdelmohsen, K., Pullmann, R., Kawai, T., Galban, S., Yang, X., Brewer, G. and Gorospe, M. (2006) Posttranscriptional derepression of GADD45alpha by genotoxic stress. Mol. Cell, 22, 117-128.
81. Mazan-Mamczarz, K., Lal, A., Martindale, J.L., Kawai, T. and Gorospe, M. (2006) Translational repression by RNA-binding protein TIAR. Mol. Cell. Biol., 26, 2716-2727.